An increased incidence of hypothyroidism by 1 year was evident with higher doses (600 MBq: 60.4% 370 MBq: 49.2%, P = 0.001 185 Bq: 38.1%, P < 0.001). Patients given a single dose of (131)I of 600 MBq (n = 485) had a higher cure rate (84.1%) compared with those receiving either 370 MBq (74.9%, P < 0.001) or those given 185 Bq (63%, P < 0.001). Probability of cure and risk of development of hypothyroidism following a single dose of (131)I.
Treatment with (131)I using a fixed dose regimen. A total of 1278 patients (1013 females and 262 males, mean age 49.7 years) presenting with hyperthyroidism between 19. Single Secondary/Tertiary Care Hospital Clinic. Consecutive series of hyperthyroid subjects treated with (131)I. To compare the efficacy of fixed dose regimens of (131)I in curing hyperthyroidism and to define simple clinical and biochemical factors that predict outcome in individual patients. There is little consensus regarding the most appropriate dose of radioiodine ((131)I) to be administered to patients with hyperthyroidism.
0 kommentar(er)
